ALS
FDA Panel Backs Much-Debated ALS Drug in Rare, 2nd Review
2022-09-08 13:02:32
by
FDA Panel Backs Much-Debated ALS Drug in Rare, 2nd Review
WASHINGTON (AP) — A panel of federal health advisers voted Wednesday to recommend approval for an experimental drug to treat Lou Gehrig’s disease, a remarkable turnaround for the much-debated medication that was previously rejected by the same group earlier this year. The... Read More
Straight From The Well
